Alerts
PDF
Other content recommended for you
- Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis
- Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down’s syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units
- Non-invasive prenatal testing for aneuploidy screening
- Non-invasive prenatal diagnosis: progress and potential
- Women’s choices in non-invasive prenatal testing for aneuploidy screening: results from a single centre prior to introduction in England
- Introducing the non-invasive prenatal testing for detection of Down syndrome in China: a cost-effectiveness analysis
- Should pregnant women be charged for non-invasive prenatal screening? Implications for reproductive autonomy and equal access
- Ethics of routine: a critical analysis of the concept of ‘routinisation’ in prenatal screening
- Cell-free fetal DNA and RNA in maternal blood: implications for safer antenatal testing
- Non-invasive prenatal testing in mitigating concerns from invasive prenatal diagnostic testing: retrospective assessment of utility in an academic healthcare system in the US